Literature DB >> 15030882

Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.

N Buchi Naidu1, K P R Chowdary, K V R Murthy, V Satyanarayana, A R Hayman, G Becket.   

Abstract

The objective of the work is physicochemical characterization of meloxicam (ME)-cyclodextrin (CD) binary systems both in solution and solid states and to improve the dissolution properties of meloxicam via complexation with alpha-, beta- and gamma-cyclodextrins. Detection of inclusion complexation was done in solution state by means of phase solubility analysis, mass spectrometry and 1H nuclear magnetic resonance (NMR) studies, and in solid state using differential scanning calorimetry (DSC), powder X-ray diffractometry, and in vitro dissolution studies. Phase solubility, mass spectrometry and 1H NMR studies in solution state revealed 1:1M complexation of meloxicam with all CDs. A true inclusion of ME with gamma-CD at 1:1 and 1:2M in solid state was confirmed by DSC, powder XRD and scanning electron microscopy (SEM) studies. Dissolution properties of ME-CDs binary systems were superior when compared to pure ME.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030882     DOI: 10.1016/j.jpba.2004.01.003

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  23 in total

1.  Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate.

Authors:  Punit P Shah; Rajashree C Mashru
Journal:  AAPS PharmSciTech       Date:  2008-09-03       Impact factor: 3.246

2.  Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility.

Authors:  Rajashree S Hirlekar; Suneeta N Sonawane; Vilasrao J Kadam
Journal:  AAPS PharmSciTech       Date:  2009-06-27       Impact factor: 3.246

Review 3.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

4.  Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.

Authors:  Mamdouh M Ghorab; Heba M Abdel-Salam; Marwa A El-Sayad; Mohammed M Mekhel
Journal:  AAPS PharmSciTech       Date:  2004-07-27       Impact factor: 3.246

5.  Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.

Authors:  Sameer Sharma; Praveen Sher; Shraddha Badve; Atmaram P Pawar
Journal:  AAPS PharmSciTech       Date:  2005-12-07       Impact factor: 3.246

6.  Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188.

Authors:  Mowafaq M Ghareeb; Alaa A Abdulrasool; Ahmed A Hussein; Mohammed I Noordin
Journal:  AAPS PharmSciTech       Date:  2009-10-28       Impact factor: 3.246

7.  Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.

Authors:  Ariana Zoppi; Alicia Delrivo; Virginia Aiassa; Marcela Raquel Longhi
Journal:  AAPS PharmSciTech       Date:  2013-04-19       Impact factor: 3.246

8.  Effect of curing on water diffusivities in acrylate free films as measured via a sorption technique.

Authors:  Dale Eric Wurster; Sushmita Bhattacharjya; Douglas R Flanagan
Journal:  AAPS PharmSciTech       Date:  2007-08-31       Impact factor: 3.246

9.  Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.

Authors:  Andreza Ribeiro; Ana Figueiras; Delfim Santos; Francisco Veiga
Journal:  AAPS PharmSciTech       Date:  2008-10-31       Impact factor: 3.246

10.  Betulin complex in γ-cyclodextrin derivatives: properties and antineoplasic activities in in vitro and in vivo tumor models.

Authors:  Codruta Soica; Cristina Dehelean; Corina Danciu; Hai Ming Wang; Gerhard Wenz; Rita Ambrus; Florina Bojin; Mariana Anghel
Journal:  Int J Mol Sci       Date:  2012-11-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.